Literature DB >> 28161424

Integration of data from a safety net health care system into the Vaccine Safety Datalink.

Simon J Hambidge1, Colleen Ross2, Jo Ann Shoup2, Kris Wain2, Komal Narwaney2, Kristin Breslin3, Eric S Weintraub4, Michael M McNeil4.   

Abstract

BACKGROUND: In 2013 the Institute of Medicine suggested that the Vaccine Safety DataLink (VSD) should broaden its population by including data of more patients from low income and racially and ethnically diverse backgrounds. In response, Kaiser Permanente Colorado (KPCO) partnered with Denver Health (DH), an integrated safety net health care system, to explore the integration of DH data.
METHODS: We compared three different methods (reference date of September 1, 2013): "Empanelment" (any patient who has had a primary care visit in the past 18months), "Proxy-enrollment" (two health care visits in 3years separated by 90days), and "Enrollment" in a managed care plan. For each of these methods, we compared cohort size, vaccination rates, socio-demographic characteristics, and health care utilization.
RESULTS: The empaneled population at DH provided the best comparison to KPCO. DH's empaneled population was 111,330 (57,173 adults; 54,157 children), while KPCO had 436,290 empaneled patients (336,462 adults; 99,828 children). Vaccination rates in both health care systems for empaneled patients were comparable. Two year-old up-to-date coverage rates were 83.2% (KPCO) and 86.9% (DH); rates for adolescent Tdap and MCV4 were 85.5% (KPCO) and 90.6% (DH). There were significant differences in the two populations in age, gender, race, preferred language, and % Federal Poverty Level (FPL) (DH 70.7%<100% FPL; KPCO 17.4%), as well as in healthcare utilization - for example pediatric emergency department utilization was twice as high at DH.
CONCLUSIONS: Using a cohort of "empaneled" patients, it is possible to integrate data from a safety net health care system that does not have a uniform managed care population into the VSD, and to compare vaccination rates, socio-demographic characteristics, and health care utilization across the two systems. The KPCO-DH collaboration may serve as a model for incorporating data from a safety net healthcare system into the VSD.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Population surveillance; Safety net health system; Vaccine safety

Mesh:

Substances:

Year:  2017        PMID: 28161424      PMCID: PMC6432770          DOI: 10.1016/j.vaccine.2017.01.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Immunization registry accuracy: improvement with progressive clinical application.

Authors:  Arthur J Davidson; Paul Melinkovich; Brenda L Beaty; Vijayalaxmi Chandramouli; Simon J Hambidge; Stephanie L Phibbs; Patricia Braun; Charles W LeBaron; John F Steiner; Brenda L Beatty
Journal:  Am J Prev Med       Date:  2003-04       Impact factor: 5.043

2.  Denver Health: a model for the integration of a public hospital and community health centers.

Authors:  Patricia Gabow; Sheri Eisert; Richard Wright
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

3.  Real-time vaccine safety surveillance for the early detection of adverse events.

Authors:  Tracy A Lieu; Martin Kulldorff; Robert L Davis; Edwin M Lewis; Eric Weintraub; Katherine Yih; Ruihua Yin; Jeffrey S Brown; Richard Platt
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

4.  America's health care safety net: revisiting the 2000 IOM report.

Authors:  Marion E Lewin; Raymond J Baxter
Journal:  Health Aff (Millwood)       Date:  2007 Sep-Oct       Impact factor: 6.301

5.  A broad and structured approach to improving patient safety and quality: lessons from Denver Health.

Authors:  Patricia A Gabow; Philip S Mehler
Journal:  Health Aff (Millwood)       Date:  2011-04       Impact factor: 6.301

Review 6.  The Vaccine Safety Datalink: a model for monitoring immunization safety.

Authors:  James Baggs; Julianne Gee; Edwin Lewis; Gabrielle Fowler; Patti Benson; Tracy Lieu; Allison Naleway; Nicola P Klein; Roger Baxter; Edward Belongia; Jason Glanz; Simon J Hambidge; Steven J Jacobsen; Lisa Jackson; Jim Nordin; Eric Weintraub
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124

7.  Integrated delivery systems: the cure for fragmentation.

Authors:  Alain C Enthoven
Journal:  Am J Manag Care       Date:  2009-12       Impact factor: 2.229

Review 8.  The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

Authors:  Michael M McNeil; Julianne Gee; Eric S Weintraub; Edward A Belongia; Grace M Lee; Jason M Glanz; James D Nordin; Nicola P Klein; Roger Baxter; Allison L Naleway; Lisa A Jackson; Saad B Omer; Steven J Jacobsen; Frank DeStefano
Journal:  Vaccine       Date:  2014-08-06       Impact factor: 3.641

9.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

10.  The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks.

Authors:  Kevin R Fahey
Journal:  EGEMS (Wash DC)       Date:  2015-12-29
View more
  6 in total

1.  Development and evaluation of a standardized research definition for opioid overdose outcomes.

Authors:  Ingrid A Binswanger; Komal J Narwaney; Edward M Gardner; Barbara A Gabella; Susan L Calcaterra; Jason M Glanz
Journal:  Subst Abus       Date:  2019-03-15       Impact factor: 3.716

2.  Development and validation of a prediction model for opioid use disorder among youth.

Authors:  Nicole M Wagner; Ingrid A Binswanger; Susan M Shetterly; Deborah J Rinehart; Kris F Wain; Christian Hopfer; Jason M Glanz
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

3.  Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment.

Authors:  Ingrid A Binswanger; Susan M Shetterly; Stanley Xu; Komal J Narwaney; David L McClure; Deborah J Rinehart; Anh P Nguyen; Jason M Glanz
Journal:  JAMA Netw Open       Date:  2022-10-03

4.  Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.

Authors:  Jason M Glanz; Komal J Narwaney; Shane R Mueller; Edward M Gardner; Susan L Calcaterra; Stanley Xu; Kristin Breslin; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2018-01-29       Impact factor: 5.128

5.  Analysis of Variation in Organizational Definitions of Primary Care Panels: A Systematic Review.

Authors:  Michael F Mayo-Smith; Rebecca A Robbins; Mark Murray; Rachel Weber; Pamela J Bagley; Elaina J Vitale; Neil M Paige
Journal:  JAMA Netw Open       Date:  2022-04-01

6.  Temporal Trends in Undervaccination: A Population-Based Cohort Study.

Authors:  Matthew F Daley; Liza M Reifler; Jo Ann Shoup; Komal J Narwaney; Elyse O Kharbanda; Holly C Groom; Michael L Jackson; Steven J Jacobsen; Huong Q McLean; Nicola P Klein; Joshua T B Williams; Eric S Weintraub; Michael M McNeil; Jason M Glanz
Journal:  Am J Prev Med       Date:  2021-04-30       Impact factor: 5.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.